|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 804.70 BDT | -0.37% |
|
-0.57% | +13.66% |
| Market Cap | 1.82B 14.7M 12.71M 11.87M 10.89M 20.48M 1.4B 20.81M 139M 54.67M 701M 55.19M 53.98M 2.32B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.79M 16.26M 15.18M 13.93M 26.2M 1.79B 26.61M 178M 69.91M 897M 70.58M 69.03M 2.96B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -0.37% | ||
| 1 week | -0.57% | ||
| Current month | -1.02% | ||
| 1 month | +5.78% | ||
| 3 months | +7.11% | ||
| 6 months | +1.49% | ||
| Current year | +13.66% |
| 1 week | 802 |  | 820 |
| 1 month | 757 | | 847 |
| Current year | 689 | | 847 |
| 1 year | 681 | | 895 |
| 3 years | 610 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 353 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.37% | -0.57% | -0.87% | +32.22% | 15.63M | |
| -0.03% | -0.97% | +20.89% | +69.03% | 49.03B | |
| -1.14% | +9.22% | +59.57% | +124.81% | 42.33B | |
| +0.27% | -0.45% | -2.47% | +16.58% | 12.43B | |
| +0.43% | -0.18% | +17.11% | +70.10% | 11.68B | |
| -0.19% | +0.39% | +31.23% | +141.20% | 9.12B | |
| +2.19% | +5.53% | +21.06% | +35.74% | 7.15B | |
| +1.62% | +3.49% | +40.44% | -13.45% | 7.09B | |
| -1.22% | +0.96% | +9.86% | +177.80% | 6.76B | |
| +6.44% | +8.26% | -24.61% | +28.68% | 5.95B | |
| Average | +0.80% | +2.44% | +17.22% | +68.27% | 15.16B | |
| Weighted average by Cap. | +0.09% | +3.77% | +28.75% | +82.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.78M 1.54M 1.43M 1.32M 2.47M 169M 2.51M 16.82M 6.6M 84.68M 6.67M 6.52M 280M | 231M 1.87M 1.61M 1.51M 1.38M 2.6M 178M 2.64M 17.69M 6.94M 89.02M 7.01M 6.85M 294M |
| Net income | 9.68M 78.38K 67.8K 63.32K 58.08K 109K 7.46M 111K 743K 292K 3.74M 294K 288K 12.36M | 5.31M 42.98K 37.18K 34.72K 31.85K 59.9K 4.09M 60.85K 407K 160K 2.05M 161K 158K 6.78M |
| Net Debt | 445M 3.6M 3.11M 2.91M 2.67M 5.02M 343M 5.1M 34.11M 13.39M 172M 13.52M 13.22M 568M | 506M 4.1M 3.55M 3.31M 3.04M 5.71M 390M 5.8M 38.84M 15.24M 195M 15.39M 15.05M 646M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/08/26 | BDT 804.70 | -0.37% | 775 |
| 06/08/26 | BDT 807.70 | -1.46% | 418 |
| 04/08/26 | BDT 819.70 | +0.61% | 950 |
| 03/08/26 | BDT 814.70 | +0.67% | 332 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
